NLRP3 and cardiac hypertrophy: Thus, mtROS can activate the NLRP3-dependent pyroptosis pathway by inducing the oxidation of GSDMD, which damages cardiomyocytes and myocardial tissue, leading to various cardiovascular conditions, including cardiac hypertrophy, atherosclerosis, and myocardial reperfusion injury [113,114,115].